Traws Pharma, Inc.

TRAW · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$21,338$20,821$38,757$55,070
Short-Term Investments$0$0$0$0
Receivables$1,765$18$29$28
Inventory$0$0$0$0
Other Curr. Assets$1,848$1,821$561$332
Total Curr. Assets$24,951$22,660$39,347$55,430
Property Plant & Equip (Net)$10$22$24$38
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1$1$1$10
Total NC Assets$11$23$25$48
Other Assets$0$0$0$0
Total Assets$24,962$22,683$39,372$55,478
Liabilities
Payables$8,186$5,619$3,860$2,757
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$226$226$226$226
Other Curr. Liab.$3,121$3,375$3,960$3,132
Total Curr. Liab.$11,533$9,220$8,046$6,115
LT Debt$0$0$0$0
Deferred Rev, NC$2,565$2,791$3,017$3,243
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$42,494$0$0$0
Total NC Liab.$45,059$2,791$3,017$3,243
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$56,592$12,011$11,063$9,358
Equity
Pref Stock$0$0$0$0
Common Stock$36$210$209$209
Retained Earnings-$649,154-$482,631-$463,683-$444,719
AOCI-$42-$23-$33-$14
Other Equity$617,530$493,116$491,816$490,644
Total Equity-$31,630$10,672$28,309$46,120
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$24,962$22,683$39,372$55,478
Net Debt-$21,338-$20,821-$38,757-$55,070